Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-030913
Filing Date
2025-03-03
Accepted
2025-03-03 16:36:18
Documents
110
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K adpt-20241231.htm   iXBRL 10-K 3971817
2 EX-19 adpt-ex19.htm EX-19 187047
3 EX-23.1 adpt-ex23_1.htm EX-23.1 6497
4 EX-31.1 adpt-ex31_1.htm EX-31.1 18488
5 EX-31.2 adpt-ex31_2.htm EX-31.2 19987
6 EX-32.1 adpt-ex32_1.htm EX-32.1 11314
7 EX-32.2 adpt-ex32_2.htm EX-32.2 12632
8 GRAPHIC img64161509_0.jpg GRAPHIC 426186
9 GRAPHIC img64161509_1.jpg GRAPHIC 631041
10 GRAPHIC img64161509_2.jpg GRAPHIC 438703
11 GRAPHIC img64161509_3.jpg GRAPHIC 426040
12 GRAPHIC img83932212_0.jpg GRAPHIC 35469
  Complete submission text file 0000950170-25-030913.txt   19912412

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT adpt-20241231.xsd EX-101.SCH 1824023
113 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20241231_htm.xml XML 3176736
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38957 | Film No.: 25698632
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)